Abbott Labs (ABT) Offering Possible 17.92% Return Over the Next 13 Calendar Days

This post was originally published on this site

Abbott Labs’s most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $118.00 short put and a strike $113.00 long put offers a potential 17.92% return on risk over the next 13 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $118.00 by expiration. The full premium credit of $0.76 would be kept by the premium seller. The risk of $4.24 would be incurred if the stock dropped below the $113.00 long put strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Abbott Labs is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.

The RSI indicator is at 76.05 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Abbott Labs

Cardiovascular Systems (CSII) Posts Break-Even Earnings in Q2
Thu, 04 Feb 2021 18:34:06 +0000
Cardiovascular Systems (CSII) registers dismal revenues despite gradual recovery in business amid the pandemic.

Becton Dickinson (BDX) Earnings Surpass Estimates in Q1
Thu, 04 Feb 2021 17:25:05 +0000
Each of Becton Dickinson’s (BDX) core units witnesses strong revenue growth in the fiscal first quarter.

Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?
Thu, 04 Feb 2021 16:30:04 +0000
Is (ABT) Outperforming Other Medical Stocks This Year?

Quest Diagnostics (DGX) Q4 Earnings Top, Base Recovery Slows
Thu, 04 Feb 2021 16:25:04 +0000
Quest Diagnostics’ (DGX) first-half 2021 outlook looks impressive thanks to strong revenue growth expectations.

Change Healthcare (CHNG) Q3 Earnings Top Estimates, Up Y/Y
Thu, 04 Feb 2021 14:30:02 +0000
Change Healthcare’s (CHNG) fiscal third-quarter results benefit from solid performance in the Network Solutions segment.

Be Sociable, Share!

Related Posts